Can you live 20 years with mid-stage cervical cancer?

Patients in the middle stage of cervical cancer can live for 20 years as long as they cooperate with the doctor's treatment, pay attention to their diet and strengthen exercise, and control the onset of the disease. This depends on the physical condition of each patient and the treatment process. Patients in the middle stage of cervical cancer should not be discouraged. As long as they receive effective treatment, the condition can be alleviated and it is possible to achieve the goal of cure.

There are many patients who have reached the middle stage of cervical cancer. They need to suppress the disease through treatment, but essentially, various treatments cannot completely cure them, which causes their lives to slowly slip away. Of course, there are some patients in the middle stage of cervical cancer who can be cured through treatment and thus avoid dying from the middle stage of cervical cancer.

There is no particularly standard answer to the question of whether a patient with mid-stage cervical cancer can live for 20 years. Because the final effects of treatment vary, and physical constitution also has a certain impact, it does not mean that every patient's survival time is fixed. Only through specific cases can we determine whether they can live for 20 years.

Some patients in the middle stage of cervical cancer have suffered too much strain on themselves, so they may only live for ten to eight years, or even shorter. Some can live beyond 20 years old after effective treatment. There are even some patients who can avoid dying from cervical cancer after spending a lot of effort to cure themselves, so they will not die from cervical cancer.

Therefore, some patients with mid-stage cervical cancer can live for 20 years, while some cannot live beyond 20 years. However, the specific survival time can only be determined after a careful examination of the case. Because the physical conditions of patients are all different, it is impossible to make an effective judgment without further confirmation under such different circumstances.

How high is the mortality rate from cervical cancer?

This is an issue that many female friends are concerned about. Cervical cancer is the most common cancer among female reproductive organ cancers. Most of the patients are middle-aged women, but in recent years there has been a trend of developing to younger age groups. In my country, the mortality rate from cervical cancer ranks fourth among all cancer mortality rates and second among female cancers.

Every year, there are 466,000 cases of cervical cancer and 231,000 deaths worldwide. The vast majority of cervical cancer patients live in developing countries, with China accounting for about one-third. The incidence rate of cervical cancer in Xinjiang is higher than the national average, and the mortality rate ranks first in the country.

Currently, the five-year overall survival rate after treatment of cervical cancer worldwide is 55.5 percent; among them, stage I is 80 percent; stage II is 58.9 percent; stage III is 32.8 percent; and stage IV is 7.1 percent. It can be seen that the earlier the treatment, the higher the survival rate.

Cervical cancer is prone to recurrence after surgery. About half of patients relapse within one year after treatment, 25% relapse in the second year, and 5% relapse after five years. Therefore, patients should have monthly checkups within one year after treatment, every two months in the second year, and every six months thereafter. A detailed pelvic examination and vaginal smear should be performed each time.

Usually, cervical cancer develops slowly. If it can be detected, diagnosed and treated early, the effects of surgery and radiotherapy will be more certain, and its prognosis is better than other cancers. Important factors affecting the prognosis of cervical cancer include tumor grade, pelvic lymph node metastasis, depth of cancer cell infiltration and invasion of lymphovascular space. Generally speaking, the prognosis of early cervical cancer is very good, and the more advanced the disease is, the worse the prognosis is.